BASKING RIDGE, N.J., Oct. 9, 2013 /PRNewswire/ -- Reproductive Medicine Associates of New Jersey, (RMANJ), a world-renowned leader in the field of Assisted Reproductive Technology (ART), will release 33 new research abstracts during the 69th Annual Meeting of the American Society for Reproductive Medicine (ASRM) being held in Boston October 12-17, 2013.
Despite having some of the highest IVF delivery rates in the US, RMANJ's mission to continuously improve the safety and success of IVF treatment for every hopeful parent will be evident again at this year's ASRM meeting. RMANJ remains committed to breakthrough scientific programs to help patients overcome infertility and advance reproductive technologies with the goal of each patient having one healthy child at a time.
Research includes a focus on genomic screening, single embryo transfer, embryo cryopreservation, extended embryo culture and impact of body mass index on oocyte yield. For a detailed list of the abstracts please go to www.rmanj.com.
"I'm extremely proud of our entire team and the culture of research, education, and collaboration we have established at RMANJ," said Richard T. Scott, Jr., M.D., F.A.C.O.G., H.C.L.D., a founding partner of RMANJ. He added, "This year's 33 abstracts represent both great quantity as well as great quality in ART research. Our team's commitment to helping every patient is inexhaustible."
In addition, four members of the RMANJ team will receive awards from ASRM for their excellence and dedication to reproductive medicine:
- Nathan Treff, PhD is the recipient of Young Investigator Award. Dr. Treff was involved in 13 of 33 research programs presented by RMANJ this year.
- Kathleen Hong, MD is the recipient Corporate Member Council In-Training Travel Grant and In- Training Award for Research
- Catherine M Bergh, MSN, RN received ASRM's Nurse Research Award for her research: Effect of Body Mass Index on Aneuploidy
- Christine Reda, BSN, RN received ASRM Nurse Research award for her research: The Impact of Body Mass Index on Lueteinization and Oocyte/Blastocyst Yield.
Abstracts of the research presented at the ASRM meeting will be published in the October 2013 issue of Fertility & Sterility.
"We are very excited about the research work that is being presented at ASRM this year and pleased with the recognition it has received by our peers. One of these collaborations was recognized by ASRM as a candidate for this year's prize paper, further illustrating the unparalleled commitment to rigorous, interdisciplinary, and innovative research at RMANJ," Nathan Treff, PhD Director of Molecular Biology Research.
For a detailed list of the abstracts please go to www.rmanj.com.
About Reproductive Medicine Associates of New Jersey
Reproductive Medicine Associates of New Jersey have pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS) to more accurately detect healthy embryos that will lead to successful pregnancies and ultimately healthy babies. Other centers have attempted similar testing methods, but RMANJ is the only fertility center in the world to have developed a system of unprecedented accuracy, fully validated through years of rigorous clinical research. RMANJ's Comprehensive Chromosome Screening offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.
The fertility experts at RMANJ have among the highest IVF success rates in the country. Since 1999, they have helped bring more than 30,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Robert Wood Johnson University Medical School in New Brunswick, NJ, the practice has seven locations in New Jersey. For more information please call RMANJ at 973-656-2089, or visit http://www.rmanj.com.
SOURCE Reproductive Medicine Associates of New Jersey